Si‐Yang Maggie Liu

机构：University of Arizona, Sun Yat-sen University, Jinan University, Hangzhou Normal University, The First People's Hospital of Shunde, Guangzhou Automobile Group (China), Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, First Affiliated Hospital of Jinan University, Southern Medical University, University of Duisburg-Essen · ORCID：0000-0002-3837-0758

发表论文 205 篇 · 总被引 4809 次 · h-index 31

代表论文

• Inflammatory and metabolic markers mediate the association of hepatic steatosis and fibrosis with 10-year ASCVD risk (2025 · Annals of Medicine · 被引 14)
• Vebreltinib in MET amplification-driven advanced non-small-cell lung cancer (KUNPENG): a single-arm, multi-cohort, multicentre, phase 2 study (2025 · The Lancet Oncology · 被引 6)
• Live biotherapeutic enterococcus lactis MNC-168 promotes the efficacy of immune checkpoint blockade in cancer therapy by activating STING pathway via bacterial membrane vesicles (2025 · Gut Microbes · 被引 5)
• Cellular dynamics in cerebrospinal fluid unveils the key regulators of intracranial response to immune checkpoint inhibitors in NSCLC brain metastases (2025 · Journal for ImmunoTherapy of Cancer · 被引 2)
• Serum essential elements and muscle health in Chinese adults: a community-based study (2025 · Nutrition & Metabolism · 被引 2)
• Comprehensive management of MET tyrosine kinase inhibitor-induced peripheral edema in patients with MET-altered non-small-cell lung cancer: a narrative review (2025 · Translational Lung Cancer Research · 被引 2)